Funder
MRC Network of Hubs for Trials Methodology Research
Medical Research Council
National Institute for Health Research
Cancer Research UK
Publisher
Springer Science and Business Media LLC
Subject
Health Informatics,Epidemiology
Reference97 articles.
1. Babb JS, Rogatko A. Bayesian methods for phase I cancer clinical trials. In: Geller NL, editor. Advances in clinical trial biostatistics. New York, NY: Marcel Dekker; 2004. p. 1–40.
2. Carter SK. Study design principles for the clinical evaluation of new drugs as developed by the chemotherapy programme of the National Cancer Institute. In: Staquet MJ, editor. The Design of Clinical Trials in Cancer Therapy. Editions Scientifique Europe; 1973. p. 242–89.
3. Le Tourneau C, Lee JJ, Siu LL. Dose escalation methods in phase I cancer clinical trials. J Natl Cancer Inst. 2009;101:708–20.
4. Rogatko A, Schoeneck D, Jonas W, Tighiouart M, Khuri FR, Porter A. Translation of innovative designs into phase I trials. J Clin Oncol. 2007;25:4982–6.
5. Chiuzan C, Shtaynberger J, Manji GA, Duong JK, Schwartz GK, Ivanova A, et al. Dose-finding designs for trials of molecularly targeted agents and immunotherapies. J Biopharm Stat. 2017;27:477–94.
Cited by
61 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献